Blood gas analysis

This tender concerns the procurement of blood gas analysis services, including oxymetry, acid-base balance, selected electrolytes, and selected metabolic parameters, for 37 specified locations as detailed in Appendix A1. Currently, 37 devices (30 x ABL90, 7 x ABL8xx) are in use. The requirement is for automated analyzers that can be configured according to the specific needs of each location, accommodating both non-cassette and cassette-based devices. A framework agreement will be established with an initial term of 5 years, commencing from the start of service or acceptance of the overall service, extending up to June 1, 2026. A single one-year extension option is included. The billing structure will be divided into device costs (one-time implementation costs + rental) and a price per test result. An estimated 300,000 analyses per year are anticipated over the entire contract duration, with prices expected to remain consistent. The framework agreement's upper limit is set at 150% of the total projected number of analyses. Minor deviations of up to 20% in quantity estimates will not result in adjustments to unit prices. The mandatory replacement of existing devices must be completed by June 1, 2026.

This is a services contract in the health and medical services and general supplies sectors, with a focus on Medical Equipment and Laboratory. Located in Germany, Europe, this opportunity is open to firms and consortiums.

Published through TED - Tenders Electronic Daily (EU), a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for services in the health and medical services sector. Service contracts are typically evaluated on both technical quality and price, and may require bidders to demonstrate relevant experience and qualified personnel. This contract has already been awarded. The information is published for transparency and market intelligence purposes.